J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)

Market Cap	353.57B +47.7%
Revenue (ttm)	42.08B +9.5%
Net Income	7.09B +17.8%
EPS	44.45 +18.1%
Shares Out	160.56M
PE Ratio	49.54
Forward PE	37.56
Dividend	19.70 (0.90%)
Ex-Dividend Date	May 29, 2026

Volume	5,648
Open	2,258.95
Previous Close	2,226.45
Day's Range	2,171.50 - 2,258.95
52-Week Range	1,603.05 - 2,284.95
Beta	-0.04
Analysts	Buy
Price Target	2,258.22 (+3.17%)
Earnings Date	May 11, 2026

About BOM:506943

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, capsules, liquids, gels, lozenges, creams, injectables, powder, cold rubs, eye drops, and troches; and soft-centered, powde...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 5,304
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506943

Financial Performance

In fiscal year 2026, BOM:506943's revenue was 42.08 billion, an increase of 7.40% compared to the previous year's 39.18 billion. Earnings were 7.09 billion, an increase of 7.56%.